Vieider, Romed P.
Wang, Jasmine
Hartline, Jacob
Watanabe, Shu
Dias, Karina
Euringer, Joseph
Sherman, Seth L.
Musahl, Volker
Funding for this research was provided by:
Technische Universität München
Article History
Received: 25 November 2025
Accepted: 19 January 2026
First Online: 6 February 2026
Declarations
:
: Conflicts of Interest: Volker Musahl declares educational grants, consulting fees and speaking fees from Smith & Nephew plc, educational grants from Arthrex and DePuy/Synthes, is a board member of the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine (ISAKOS), and deputy editor‐in‐chief of Knee Surgery, Sports Traumatology, Arthroscopy (KSSTA)Seth Sherman holds committee positions for AANA, AAOS, ACLSG, AOSSM, Biologic Association, ICRS, and ISAKOS; is on the editorial board for Arthroscopy, Current Reviews in Musculoskeletal Medicine, and VJSM; is a course chair of ISMF and the PFF Masters Course; is a member of the AO Sports Medicine Taskforce; is a paid educational consultant for Arthrex, Depuy, Flexion, JRF, Kinamed, LifeNet, NewClip, and Smith & Nephew; is a paid advisory board member for Bioventus, Ostesys, Reparel, Sarcio, Sparta Medical, Vericel, and Vivorte; is on design teams and receives royalties from ConMed and DJO; holds stock options in Ostesys, Sarcio, Reparel, and Vivorte; has received nonconsulting fees from Arthrex, Smith & Nephew, Synthes GmbH, Vericel, and Linvatec; has received consulting fees from Flexion Therapeutics, Bioventus, Biorez, DJO, DePuy Synthes Products, Kinamed, Linvatec, Medical Device Business Services, Pacira Pharmaceuticals, Smith & Nephew, Vericel, JRF Ortho, LifeNet Health, Ceterix Orthopaedics, Joint Restoration Foundation, and Olympus America; has received education payments from Evolution Surgical; received travel and lodging from Smith & Nephew, Linvatec Corporation, Vericel Corporation, Arthrex, Flexion Therapeutics, Joint Restoration Foundation, Aesculap Biologics, and Synthes GmbH; received food and beverage from Smith & Nephew, Linvatec Corporation, Vericel Corporation, Arthrex, Joint Restoration Foundation, Aescuplap Biologics, and Stryker Corporation; received honoraria from Vericel Corporation, Flexion Therapeutics, and Joint Restoration Foundation; received compensation for services other than consulting (including serving as faculty or as a speaker at a venue other than a continuing education program) from Smith & Nephew; received compensation for serving as faculty or as a speaker for a nonaccredited and noncertified continuing education program and royalties or licenses from Linvatec Corporation; received grants from DJO; received educational support from Elite Orthopedics; and received compensation for serving as a faculty or speaker for an accredited or certified continuing education program from Synthes GmbH. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.